pyrimethamine has been researched along with af-219 in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Evers, R; Garrett, G; Hussain, A; Iwamoto, M; Li, Y; Ma, B; Min, KC; Nussbaum, JC; Stoch, SA | 1 |
1 other study(ies) available for pyrimethamine and af-219
| Article | Year |
|---|---|
Assessment of the Effect of Pyrimethamine, a Potent Inhibitor of Multidrug and Toxin Extrusion Protein 1/2K, on the Pharmacokinetics of Gefapixant (MK-7264), a P2X3 Receptor Antagonist.
Topics: Humans; Purinergic P2X Receptor Antagonists; Pyrimethamine; Pyrimidines; Receptors, Purinergic P2X3; Sulfonamides | 2022 |